Lista de obras -

A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity

scientific article published on 22 November 2019

A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family

artículo científico publicado en 2006

Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine

artículo científico publicado en 2010

An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples

artículo científico publicado en 2007

Aromatase inhibition: translation into a successful therapeutic approach

artículo científico publicado en 2005

Aromatase inhibitors as adjuvant treatment of breast cancer

artículo científico publicado en 2005

Aromatase inhibitors--socio-economical issues

artículo científico publicado en 2005

Aromatase inhibitors--socioeconomical issues

artículo científico publicado en 2007

Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

artículo científico publicado en 2007

Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status

artículo científico publicado en 2009

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

artículo científico publicado en 2012

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes

artículo científico publicado en 2015

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors

artículo científico publicado en 2013

Development of aromatase inhibitors and their pharmacologic profile

artículo científico publicado en 2003

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma

artículo científico publicado en 2013

Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?

artículo científico publicado en 2006

Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer

artículo científico publicado en 2005

Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer

artículo científico publicado en 2005

Endocrine effects of aromatase inhibitors and inactivators in vivo: review of data and method limitations

artículo científico publicado en 2005

Experience with exemestane in the treatment of early and advanced breast cancer

scientific article published on 01 July 2008

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

artículo científico publicado en 2005

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome

artículo científico publicado en 2010

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

artículo científico publicado en 2015

Impact of aromatase inhibitors on bone health in breast cancer patients

artículo científico publicado en 2009

Indications and limitations of third-generation aromatase inhibitors

scientific article published on 01 May 2008

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

artículo científico publicado en 2002

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome

artículo científico publicado en 2017

Intratumoral estrogen disposition in breast cancer

artículo científico publicado en 2010

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

artículo científico publicado en 2008

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

artículo científico publicado en 2013

MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.

artículo científico publicado en 2010

Molecular profiling reveals low- and high-grade forms of primary melanoma

artículo científico publicado en 2012

Multilocus analysis of SNP and metabolic data within a given pathway

artículo científico publicado en 2006

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

artículo científico publicado en 2022

Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens

artículo científico publicado en 2014

Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer

scientific article published on 21 August 2018

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer

artículo científico publicado en 2003

The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer

scientific article published on 19 June 2019

The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors

scientific article published on 12 September 2019

Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels

artículo científico publicado en 2007

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers

artículo científico publicado en 2016

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients

artículo científico publicado en 2005

Lista de obras de

A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity

A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family

Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine

An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples

Aromatase inhibition: translation into a successful therapeutic approach

Aromatase inhibitors as adjuvant treatment of breast cancer

Aromatase inhibitors--socio-economical issues

Aromatase inhibitors--socioeconomical issues

Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors

Development of aromatase inhibitors and their pharmacologic profile

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma

Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?

Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer

Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer

Endocrine effects of aromatase inhibitors and inactivators in vivo: review of data and method limitations

Experience with exemestane in the treatment of early and advanced breast cancer

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

Impact of aromatase inhibitors on bone health in breast cancer patients

Indications and limitations of third-generation aromatase inhibitors

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome

Intratumoral estrogen disposition in breast cancer

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.

Molecular profiling reveals low- and high-grade forms of primary melanoma

Multilocus analysis of SNP and metabolic data within a given pathway

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens

Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer

The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer

The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors

Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients